25% Dextrose Injection — Class II drug recall D-0577-2020
Terminated recall by Pfizer Inc., reported 2019-12-18, distributed nationwide. Labeling: Incorrect or Missing Lot and/or expiration date.
| Recall number | D-0577-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pfizer Inc., New York, NY, United States |
| Recall initiated | 2019-11-27 |
| Classified | 2019-12-06 |
| Reported by FDA | 2019-12-18 |
| Terminated | 2022-01-14 |
| Distributed | Nationwide (US) |
| Quantity | 77,100 syringes |
| Reason classes | labeling |
| NDC | 00409-1775, 00409-1775-10, 00409-1775-40 |
| Lot numbers | 1AUG2019, 80-292-EV |
Product
25% Dextrose Injection, USP 2.5 grams (250 mg/mL) 10 mL Single-dose, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-1775-10
Reason for recall
Labeling: Incorrect or Missing Lot and/or expiration date.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0577-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.